We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
+5.74%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$696M
AUM Growth
-$122M
(-15%)
Cap. Flow
-$135M
Cap. Flow
% of AUM
-19.45%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
329
New
119
Increased
34
Reduced
64
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$23.2M |
| 2 |
PepsiCo
PEP
|
+$13.1M |
| 3 |
AbbVie
ABBV
|
+$10.1M |
| 4 |
Elevance Health
ELV
|
+$9.59M |
| 5 |
Abbott
ABT
|
+$8.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$22.4M |
| 2 |
Pfizer
PFE
|
+$18M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$13.1M |
| 4 |
Pediatrix Medical
MD
|
+$11.2M |
| 5 |
Danaher
DHR
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.68% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Industrials | 7.26% |
| 4 | Consumer Staples | 5.08% |
| 5 | Communication Services | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Ashland
ASH
$3.33B
| – | – |
-43,153
| Closed | -$2.69M |
|
227
Best Buy
BBY
$18.5B
| – | – |
-2,955
| Closed | -$112K |
|
228
Boise Cascade
BCC
$2.65B
| – | – |
-90,041
| Closed | -$3.29M |
|
229
Becton Dickinson
BDX
$45.6B
| – | – |
-43,673
| Closed | -$6.12M |
|
230
Bunge Global
BG
$20.2B
| – | – |
-72,533
| Closed | -$5.97M |
|
231
Bausch Health
BHC
$2.25B
| – | – |
-35,000
| Closed | -$6.95M |
|
232
CALL
Brookdale Senior Living
BKD
$3.49B
| – | – |
-75,000
| Closed | -$2.83M |
|
233
BioMarin Pharmaceuticals
BMRN
$11.7B
| – | – |
-18,000
| Closed | -$2.24M |
|
234
BWX Technologies
BWXT
$15.2B
| – | – |
-213,872
| Closed | -$4.91M |
|
235
CALL
Conagra Brands
CAG
$7.19B
| – | – |
-128,500
| Closed | -$3.65M |
|
236
Coca-Cola Europacific Partners
CCEP
$49.3B
| – | – |
-106,442
| Closed | -$4.71M |
|
237
Clean Harbors
CLH
$16.7B
| – | – |
-53,126
| Closed | -$2.97M |
|
|
VISN
238
Vistance Networks Inc
VISN
$2.64B
| – | – |
-12,136
| Closed | -$346K |
|
239
Criteo S.A. Ordinary Shares
CRTO
$1.1B
| – | – |
-11,831
| Closed | -$467K |
|
240
Constellium
CSTM
$3.87B
| – | – |
-30,663
| Closed | -$623K |
|
241
CALL
Deere & Co
DE
$162B
| – | – |
-60,000
| Closed | -$5.26M |
|
|
242
Danaher
DHR
$138B
| – | – |
-194,366
| Closed | -$11.1M |
|
243
Dine Brands
DIN
$457M
| – | – |
-32,393
| Closed | -$3.47M |
|
244
Dollar Tree
DLTR
$24.7B
| – | – |
-12,625
| Closed | -$1.02M |
|
245
eBay
EBAY
$50.4B
| – | – |
-47,154
| Closed | -$1.15M |
|
246
Ecolab
ECL
$78.6B
| – | – |
-17,851
| Closed | -$2.04M |
|
247
PUT
Emerson Electric
EMR
$83.3B
| – | – |
-100,000
| Closed | -$5.66M |
|
248
CALL
Fastenal
FAST
$53.5B
| – | – |
-640,000
| Closed | -$6.63M |
|
249
Fortune Brands Innovations
FBIN
$5.88B
| – | – |
-9,587
| Closed | -$389K |
|
250
Fidelity National Financial
FNF
$14B
| – | – |
-84,232
| Closed | -$2.15M |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Catapult Capital Management held 329 positions worth $696M, down 15% from $818M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Catapult Capital Management withdrew a net $135M in Q2 2015, closing 111 positions and reducing 64 holdings. Its most notable exit was Pfizer, an estimated $18M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Catapult Capital Management opened a new position in Zoetis worth $23.5M.
- Catapult Capital Management's largest Q2 2015 buy was Zoetis: 486,665 shares worth $23.5M.
- Catapult Capital Management added most to AbbVie in Q2 2015, an estimated $10.1M increase.
- Catapult Capital Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $22.4M.
- Catapult Capital Management fully exited Pfizer in Q2 2015, selling an estimated $18M.
- Catapult Capital Management's ten largest holdings make up 24% of its $696M portfolio in Q2 2015.
- Catapult Capital Management opened 119 new positions and closed 111 in Q2 2015.
- Catapult Capital Management's portfolio value fell 15% quarter-over-quarter to $696M.
Based on Catapult Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.